← stocks-llm Find companies like DVA →

DaVita (DVA)

Health Care · Dialysis and kidney care services

Leading US dialysis and integrated kidney care provider serving end-stage renal disease patients across clinical centers, home-based settings, and transplant support globally.

What DaVita does

DaVita is a comprehensive kidney care provider delivering dialysis treatments and nephrology services to patients with chronic kidney disease and end-stage renal disease (ESRD). The company operates a large network of US outpatient dialysis centers and approximately 585 international dialysis centers across 14 countries, serving approximately 94,500 patients internationally. DaVita also provides integrated kidney care (IKC) services managing disease progression and supporting kidney transplantation, alongside ancillary nephrology services and vascular access care.

Themes: ["Chronic kidney disease management","ESRD/dialysis care","Integrated care models","Kidney transplantation support","CMS Quality Incentive Program performance","International healthcare services","Home-based dialysis","Preventive nephrology"]

Fundamentals

Ask why DVA looks like this →

Key risks (from latest filing)

["Regulatory and reimbursement pressure: Medicare/Medicaid rates and CMS quality program changes directly impact dialysis pricing and volume","Clinical outcomes and quality performance: Poor results in CMS QIP benchmarks could reduce reimbursement and patient volumes","International operations complexity: 585 dialysis centers in 14 countries expose company to currency, regulatory, and operational risks"]

See DVA's biggest risks from its latest 10-Q →

Competitors & peers

Not quite? Describe exactly what you want →

Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-07-09.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.